If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
396.00    6.50 (1.67%)
Bid:
391.00
Ask:
397.00
Spread: 6.00 (1.535%)
Market Cap: £1.79b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Total Voting Rights

12 Nov 2012 15:57

HgCapital Trust PlcTotal Voting Rights

In conformity with the Disclosure and Transparency rule 5.6.1A, we would like to notify the market of the following:

As at 12 November, the issued share capital and voting rights of HgCapital Trust Plc are as follows:

Class of share Total number of Number of voting

Ordinary shares in rights attached to circulation each share Ordinary 35,564,185 125p Shares Class of share Number of Number of voting

Subscription shares rights attached to in circulation each share Subscription 1,760,513 01p Shares Total Total number number of voting of shares rights of shares in in issue circulation 37,324,698 35,564,185

The above total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in HgCapital Trust Plc under the FSA's Disclosure and Transparency Rules.

12 November 2012

XLON
Date   Source Headline
12th Nov 20124:23 pmPRNHolding(s) in Company
12th Nov 20123:57 pmPRNTotal Voting Rights
9th Nov 201210:56 amPRNSubscription Share Exercise and Listing Application
7th Nov 20127:00 amPRNPerformance at Month End
1st Nov 20127:00 amPRNExercise of Subscription shares
26th Oct 20121:53 pmPRNHolding(s) in Company
10th Oct 20127:00 amPRNInterim Management Statement
8th Oct 20129:06 amRNSHgCapital announces investment in Valueworks
26th Sep 20124:00 pmPRNCircular re Subscription Notice
7th Sep 20127:00 amPRNPerformance at Month End
30th Aug 201210:27 amPRNCorrection: Holdings in Company
30th Aug 201210:25 amPRNCorrection: Holdings in Company
29th Aug 20126:14 pmPRNHolding(s) in Company
29th Aug 20126:02 pmPRNHolding(s) in Company
23rd Aug 20127:02 amPRNHalf-yearly Report
23rd Aug 20127:00 amRNSHalf Yearly Report
17th Aug 20127:00 amRNSHgCapital announces sale of Mercury Pharma
3rd Jul 20127:00 amRNSHgCapital announces the sale of SHL
2nd Jul 20126:00 pmPRNTotal Voting Rights
28th Jun 20127:00 amRNSPre-close update
11th Jun 20125:56 pmPRNSubscription Share Exercise and Listing Application
8th Jun 201211:38 amPRNHolding(s) in Company
7th Jun 20127:00 amPRNPerformance at Month End
10th May 20125:09 pmPRNResult of AGM
10th May 201212:00 pmPRNInterim Management Statement
3rd May 20127:00 amRNSHgCapital announces investment in Qundis Group
26th Apr 201210:36 amPRNCircular re Subscription Notice
12th Apr 20129:00 amPRNAnnual Information Update
5th Apr 20127:00 amPRNPerformance at Month End
26th Mar 201210:00 amPRNDividend Declaration
16th Mar 20123:11 pmPRNDirector/PDMR Shareholding
16th Mar 20123:11 pmPRNDirector/PDMR Shareholding
16th Mar 20127:00 amRNSFinal Results
16th Mar 20127:00 amPRNAnnual Financial Report
14th Mar 20123:39 pmPRNHolding(s) in Company
24th Feb 201211:57 amPRNHolding(s) in Company
24th Feb 201211:55 amPRNHolding(s) in Company
16th Feb 201212:07 pmPRNHolding(s) in Company
20th Dec 20117:05 amRNSManager's Update announcement
7th Dec 201110:36 amRNSHgCapital re-invests in IRIS - Replacement
7th Dec 20117:00 amRNSHgCapital re-invests in UK business software firms
6th Dec 20117:00 amPRNPerformance at Month End
1st Dec 20113:15 pmPRNTotal Voting Rights
11th Nov 20111:31 pmPRNSubscription share exercise and Listing application
7th Nov 20117:00 amPRNPerformance at Month End
4th Nov 20114:03 pmPRNDirector/PDMR Shareholding
29th Sep 20115:36 pmPRNCircular re Subscription Notice
7th Sep 20113:56 pmPRNPerformance at Month End
25th Aug 20117:00 amRNSInterim Results
25th Aug 20117:00 amPRNHalf-yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.